The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Hypervirulent M. tuberculosis W/Beijing Strains Upregulate Type I IFNs and Increase Expression of Negative Regulators of the Jak-Stat Pathway
Abstract
The role of type I interferons (IFNs) in the host response to bacterial infections is controversial. Here, we examined the role of IFN-alpha/beta in the murine response to infection with Mycobacterium tuberculosis, using wildtype mice, mice with impaired signaling through the type I IFN receptor (IFNAR), and mice treated to reduce levels of type I IFNs. In this study, we used virulent clinical isolates of M. tuberculosis, including HN878, W4, and CDC1551. Our results indicate that higher levels of type I IFNs are induced by the HN878 and W4 strains. Induction of type I IFNs was associated with lower levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin- 12 (IL-12) and reduced T cell activation, and associated with decreased survival of the mice infected with HN878 or W4 relative to infection with CDC1551. Infection of mice with HN878 and W4 was also associated with relatively higher levels of mRNA for a number of negative regulators of the Jak-Stat signaling pathway, such as suppressors of cytokine signaling (SOCS) 1, 4, and 5, CD45, protein inhibitor of activated Stat1 (PIAS1), protein tyrosine phosphatase nonreceptor type 1 (Ptpn1), and protein tyrosine phosphatase nonreceptor type substrate 1 (Ptpns1). Taken together, these results suggest that increased type I IFNs may be deleterious for survival of M. tuberculosis-infected mice in association with reduced Th1 immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,465
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Signaling through the JAK/STAT pathway, recent advances and future challenges
Kisseleva, T., Bhattacharya, S., Braunstein, J., & Schindler, C. W. (2002) · Gene · doi:10.1016/s0378-1119(02)00398-0 · Cited by 1,154
SOCS Proteins: Negative Regulators of Cytokine Signaling
Krebs, D. L., & Hilton, D. J. (2001) · STEM CELLS · doi:10.1634/stemcells.19-5-378 · Cited by 827
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
Reed, M. B., Domenech, P., Manca, C., Su, H., Barczak, A. K., Kreiswirth, B. N., Kaplan, G., & Barry, C. E. (2004) · Nature · doi:10.1038/nature02837 · Cited by 762
Self-citationInterferons α and β as Immune Regulators—A New Look
Biron, C. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00154-6 · Cited by 667
Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 595
Self-citationHuman macrophage activation programs induced by bacterial pathogens
Nau, G. J., Richmond, J. F. L., Schlesinger, A., Jennings, E. G., Lander, E. S., & Young, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022649799 · Cited by 568
Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection
O'Connell, R. M., Saha, S. K., Vaidya, S. A., Bruhn, K. W., Miranda, G. A., Zarnegar, B., Perry, A. K., Nguyen, B. O., Lane, T. F., Taniguchi, T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040712 · Cited by 489
Caruso, A. M., Serbina, N. V., Klein, E. C., Triebold, K. J., Bloom, B. R., & Flynn, J. L. (1999) · PubMed · Cited by 489
Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes
Auerbuch, V., Brockstedt, D. G., Meyer-Morse, N., O'Riordan, M., & Portnoy, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040976 · Cited by 450
Caruso, A. M., Serbina, N., Klein, E., Triebold, K., Bloom, B. R., & Flynn, J. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5407 · Cited by 418
An Outbreak Involving Extensive Transmission of a Virulent Strain of Mycobacterium tuberculosis
Valway, S. E., Sanchez, M. P. C., Shinnick, T. F., Orme, I., Agerton, T., Hoy, D., Jones, J. S., Westmoreland, H., & Onorato, I. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381001 · Cited by 386
Interferons and Other Cytokines
Hendrzak, J. A., & Brunda, M. J. (1997) · Cancer Therapeutics · doi:10.1007/978-1-59259-717-8_13 · Cited by 356
Denis, M. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90014-3 · Cited by 333
Ting, L. M., Kim, A. C., Cattamanchi, A., & Ernst, J. D. (1999) · PubMed · Cited by 315
Manca, C., Tsenova, L., Barry, C. E., Bergtold, A., Freeman, S., Haslett, P. A. J., Musser, J. M., Freedman, V. H., & Kaplan, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6740 · Cited by 306
Self-citationCousens, L. P., Orange, J. S., Su, H. C., & Biron, C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.634 · Cited by 304
Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox
Nguyen, K. B., Cousens, L. P., Doughty, L. A., Pien, G. C., Durbin, J. E., & Biron, C. A. (2000) · Nature Immunology · doi:10.1038/76940 · Cited by 303
Restraining mycobacteria: Role of granulomas in mycobacterial infections
Saunders, B. M., & Cooper, A. M. (2000) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2000.00933.x · Cited by 303
Cousens, L. P., Peterson, R., Hsu, S., Dorner, A., Altman, J. D., Ahmed, R., & Biron, C. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1315 · Cited by 290
The function of type I interferons in antimicrobial immunity
Bogdan, C. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00111-4 · Cited by 276
Ting, L.-M., Kim, A. C., Cattamanchi, A., & Ernst, J. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3898 · Cited by 257
IFNs and STATs in innate immunity to microorganisms
Decker, T., Stockinger, S., Karaghiosoff, M., Müller, M. M., & Kovarik, P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15770 · Cited by 229
Differential Monocyte Activation Underlies Strain-Specific Mycobacterium tuberculosis Pathogenesis
Manca, C., Reed, M. B., Freeman, S., Mathema, B., Kreiswirth, B., Barry, C. E., & Kaplan, G. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5511-5514.2004 · Cited by 221
Self-citationGingras, S., Parganas, E., Pauw, A. D., Ihle, J. N., & Murray, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411043200 · Cited by 158
Self-citationLaochumroonvorapong, P., Wang, J., Liu, C. C., Ye, W., Moreira, A. L., Elkon, K. B., Freedman, V. H., & Kaplan, G. (1997) · Infection and Immunity · doi:10.1128/iai.65.1.127-132.1997 · Cited by 138
Self-citationCooper, A. M., Pearl, J. E., Brooks, J. V., Ehlers, S., & Orme, I. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6879-6882.2000 · Cited by 135
Hussain, S., Zwilling, B. S., & Lafuse, W. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2041 · Cited by 131
Hussain, S., Zwilling, B. S., & Lafuse, W. P. (1999) · PubMed · Cited by 111
Tobian, A. A. R., Potter, N., Ramachandra, L., Pai, R. K., Convery, M., Boom, W. H., & Harding, C. V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1413 · Cited by 110
What do microarrays really tell us about M. tuberculosis?
Kendall, S. L., Rison, S., Movahedzadeh, F., Frita, R., & Stoker, N. G. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.10.005 · Cited by 81
Imai, K., Kurita-Ochiai, T., & Ochiai, K. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00231-1 · Cited by 81
Bouchonnet, F., Boéchat, N., Bonay, M., & Hance, A. J. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.3020-3025.2002 · Cited by 73
Mattner, J., Schindler, H., Diefenbach, A., Röllinghoff, M., Gresser, I., & Bogdan, C. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(2000)30:8<2257::aid-immu2257>3.0.co;2-u · Cited by 69
Mariotti, S., Teloni, R., Iona, E., Fattorini, L., Romagnoli, G., Gagliardi, M. C., Orefici, G., & Nisini, R. (2004) · Infection and Immunity · doi:10.1128/iai.72.8.4385-4392.2004 · Cited by 45
Aerosol Infection of Mice with Mycobacteria Using a Nose-Only Exposure Device
Tsenova, L., Moreira, A. L., Party, E., Freedman, V. H., & Kaplan, G. (1997) · Applied Biosafety · doi:10.1177/109135059700200307 · Cited by 17
Self-citation
Cited by
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
ISG15 in antiviral immunity and beyond
Perng, Y.-C., & Lenschow, D. J. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0020-5 · Cited by 855
Type I interferon: friend or foe?
Trinchieri, G. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 844
Metadata
- Authors
- Manca, C., Tsenova, L., Freeman, S., Barczak, A. K., Tovey, M., Murray, P. J., Barry, C., & Kaplan, G.
- Venue
- Journal of Interferon & Cytokine Research
- Publisher
- SAGE Publications
- Published
- 2005-11
- Volume
- 25
- Issue
- 11
- Pages
- 694-701
- ISSN
- 1079-9907 (ISSN-L)
- 1557-7465
- OpenAlex
- W2132393943
- Cited by
- 294
- References
- 37
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.